Gastric cancer (GC) is a relevant public health issue as its incidence and mortality rates are
growing worldwide. There are recognized carcinogen agents, such as obesity, tobacco …

The European Society of Gastrointestinal Endoscopy and United European
Gastroenterology present a short list of key performance measures for lower gastrointestinal …

MR1 ESGE recommends small-bowel capsule endoscopy as the first-line examination,
before consideration of other endoscopic and radiological diagnostic tests for suspected …

Climate change and the destruction of ecosystems by human activities are among the
greatest challenges of the 21st century and require urgent action. Health care activities …

Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …

Background and Aims Standardized registration and evaluation of adverse events (AEs) are
essential to assess the safety of endoscopic procedures. We propose a novel classification …

Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis.
Risk factors include Helicobacter pylori infection, family history of gastric cancer—in …

MR1 ESGE recommends the following standards for Barrett esophagus (BE) surveillance:–a
minimum of 1-minute inspection time per cm of BE length during a surveillance endoscopy …

This ESGE Position Statement defines the expected value of artificial intelligence (AI) for the
diagnosis and management of gastrointestinal neoplasia within the framework of the …

Objective Esophagogastroduodenoscopy (EGD) is the pivotal procedure in the diagnosis of
upper gastrointestinal lesions. However, there are significant variations in EGD performance …